Earnings History Data for Context Therapeutics Inc. (CNTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Context Therapeutics Inc.
Context Therapeutics Inc. is a women's oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. Context Therapeutics Inc. is headquartered in Philadelphia, PA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | PM | CNTX | Context Therapeutics Inc. | 167.00 | -0.22 | -0.11 | 0.00 | Context Therapeutics GAAP EPS of -$0.22 [11/7/2024 6:26 AM] |
2.08 | -0.14 (-6.31%) |
2.10 | -0.12 (-5.40%) |
0.77 - 2.75 | 100,390 | 250,000 | 1,941 | ||
| 07-08-2024 | AH | CNTX | Context Therapeutics Inc. | 167.00 | -0.04 | -0.08 | 0.00 | Context Therapeutics GAAP EPS of -$0.04 [8/8/2024 10:27 AM] |
2.41 | 0.07 (2.99%) |
2.39 | 0.05 (2.14%) |
0.77 - 2.54 | 44,381 | 100,000 | 494 | ||
| 21-03-2024 | PM | CNTX | Context Therapeutics Inc. | 18.00 | -0.42 | -0.35 | 0.00 | Context Therapeutics reports FY results [3/21/2024 10:44 AM] |
1.09 | -0.06 (-5.22%) |
1.24 | 0.09 (7.83%) |
0.47 - 1.69 | 80,882 | 50,000 | 23,202 | ||
| 09-11-2022 | AH | CNTX | Context Therapeutics Inc. | 19.00 | -0.24 | -0.25 | 0.00 | Context Therapeutics GAAP EPS of -$0.24 beats by $0.01 [11/9/2022 5:36 PM] |
1.14 | -0.01 (-0.87%) |
1.12 | -0.03 (-2.61%) |
0.95 - 10.87 | 92,002 | 120,000 | 1,755 | ||
| 11-05-2022 | AH | 4:00 PM ET (May 11) |
CNTX | Context Therapeutics Inc. | 22.00 | -0.22 | -0.24 | 0.00 | Context Therapeutics GAAP EPS of -$0.22 [5/11/2022 4:41 PM] |
1.35 | 0.06 (4.65%) |
1.21 | -0.08 (-6.20%) |
1.27 - 10.87 | 95,774 | 190,000 | 4,836 | |